* Zynex Inc ZYXI.OQ reported quarterly adjusted earnings
of 7
cents per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of 10
cents. The mean expectation of three analysts for the quarter
was for earnings of 6 cents per share. Wall Street expected
results to range from 5 cents to 7 cents per share.
* Revenue rose 0.1% to $49.97 million from a year ago;
analysts
expected $50.83 million.
* Zynex Inc's reported EPS for the quarter was 7 cents.
* The company reported quarterly net income of $2.38
million.
* Zynex Inc shares had risen by 5.3% this quarter and
lost 21.1%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Zynex Inc is
16.75
This summary was machine generated from LSEG data October 27 at
03:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.06 0.07 Beat
Jun. 30 2024 0.08 0.04 Missed
Mar. 31 2024 0.03 0.00 Missed
Dec. 31 2023 0.17 0.21 Beat